Accumulating evidence suggests that enhanced peroxynitrite (ONOO -) formation occurs during inflammation. We have studied the impact and the mechanisms of ONOO -action on expression of adhesion molecules on human neutrophils and coronary artery endothelial cells (HCAEC) and binding of neutrophils to HCAEC. Addition of ONOO -(0.1 to 200 0WRLVRODWHGQHXWURSKLOV resulted in a concentration-dependent down-regulation of L-selectin expression, and upregulation of CD11b/CD18 expression. ONOO -stimulation of Erk activity was accompanied by activation of Ras, Raf-1 and MEK (mitogen-activated protein kinase kinase), and was sensitive to the MEK inhibitor PD 98059. We have observed a tight association between Erk activation and changes in CD11b/CD18 expression. ONOO -also evoked activation of neutrophil p38 MAPK. Neither ONOO --induced up-regulation of CD11b/CD18 expression nor Erk activation was affected by SB 203580, a selective inhibitor of p38 MAPK. ONOO -by itself had little effect on expression of ICAM-1 and E-selectin on HCAEC, whereas it markedly enhanced attachment of neutrophils to lipopolysaccharide-activated HCAEC only when it was added together with neutrophils. Increases in neutrophil adhesion evoked by ONOO -were blocked by an anti-CD18 monoclonal antibody. These data suggest that ONOO -activates Erk in neutrophils via the Ras/Raf-1/MEK signal transduction pathway, leading to up-regulation of surface expression of CD11b/CD18 and consequently to increased neutrophil adhesion to endothelial cells.
D
understood. In particular, little is known regarding the actions of ONOO -on leukocyte accumulation, a characteristic feature of inflammation and tissue injury. Lefer et al. (9) reported that nanomolar concentrations of ONOO -inhibited adhesion of neutrophil granulocytes to the endothelium in the rat mesenteric vascular bed via down-regulation of P-selectin expression on the endothelial surface. In contrast with this report, recent studies showed that scavenging ONOO -by uric acid decreases the invasion of inflammatory cells into the spinal cord in a mouse model of multiple sclerosis and prevents the development of the disease (10) . Treatment of rats with a ONOO -decomposition catalyst (FeTMPS) (11) markedly reduced tissue myeloperoxidase level (a marker of neutrophil infiltration) and injury to the distal ileum evoked by ischemia/reperfusion (12) . These latter studies raised the possibility that ONOO -may promote leukocyte trafficking, yet the question whether ONOO -itself could enhance leukocyteendothelial cell attachment as well as the underlying cellular mechanisms have not been addressed.
Leukocyte extravasation into tissues involves a multi-step interaction of leukocytes and endothelial cells via regulated expression of surface adhesion molecules (13, 14) . The initial capture and tethering of circulating neutrophils (PMNs) to the endothelium is mediated by selectins expressed on leukocytes (L-selectin) or on activated endothelial cells (P-and Eselectins). L-selectin is shed rapidly after cell activation with a concomitant up-regulation of CD11b/CD18 (Mac-1) (15) . The 2 integrins Mac-1 and LFA-1 (CD11a/CD18) are largely responsible for subsequent tightening of the adhesion and transendothelial migration of neutrophils via their endothelial counterligands, intercellular adhesion molecule-1 (ICAM-1) and ICAM-2 (13, 14) .
Specific neutrophil functions appear to be regulated, at least in part, via distinct signaling mechanisms. Studies on the mitogen-activated protein kinases (MAPKs) in neutrophils indicate an association between chemoattractant or arachidonic acid stimulation of the serine/threonine protein kinases p44 (Erk1) and p42 (Erk2) and neutrophil adhesive function (16) (17) (18) , but not superoxide generation (19) . Erk activation is mediated, at least in part, through activation of Ras, Raf-1, and MAPK kinase (MEK) (17, 20, 21) with kinetics concordant with rapid activation of neutrophils by these stimuli. These studies suggested a novel, non-mitotic signaling function for Erk in neutrophils.
In this study, we investigated whether ONOO -could affect adhesion molecule expression on human neutrophils and coronary artery endothelial cells (HCAEC), and consequently adhesion of PMNs to HCAEC, and addressed the underlying cellular and molecular mechanisms.
MATERIALS AND METHODS

Antibodies and reagents
Except where otherwise noted, reagents were from Sigma Chemical Co. (St. Louis, Mo.). In these studies, the monoclonal antibodies (mAbs) used included FITC-conjugated mouse antihuman L-selectin mAb DREG-56 (PharMingen, San Diego, Calif.); R-phycoerythrin-conjugated mouse anti-human CD11b mAb Leu-15 (Becton Dickinson Immunocytometry Systems, Mountain View, Calif.); R-phycoerythrin-conjugated mouse anti-human CD18 mAb MEM-48 (Monosan, Uden, The Netherlands); FITC-labeled mouse anti-human CD11a mAb G-25.2 (Becton Dickinson); FITC-labeled mouse anti-human E-selectin mAb 1.2B6 (Serotec, Kidlington, England); and R-phycoerythrin-conjugated mouse anti-human ICAM-1 mAb HA58 (PharMingen). The following function-blocking murine mAbs were used in neutrophilendothelial cell-adhesion assays: anti-L-selectin mAb DREG-56 (IgG 1 , PharMingen), anti-Eselectin mAb ENA-2 (IgG 1 , purified F(ab') 2 fragments, Monosan), and anti-CD18 mAb L130 (IgG 1 , Becton-Dickinson). The irrelevant mAb MOPC-21 (IgG 1 , PharMingen) was used as a negative control. Antisera specific for Raf-1 (C-12) and normal rabbit IgG were from Santa Cruz %LRWHFKQRORJ\>-32 P]ATP was from DuPont-New England Nuclear. SB 203580 and PD 98059 were from Calbiochem.
Stock solutions of peroxynitrite (160-180 mM, Alexis Biochemicals, San Diego, Calif.) were stored at -80°C at pH 12.7. Because these solutions contain nitrite, hydrogen peroxide (3.4 mM), and NaCl, a pH-neutralized negative control solution that contains the same concentrations of nitrite, H 2 O 2 , and NaCl as the ONOO -stock solution (decomposed ONOO -), and NaOH at 10 0WKHILQDOFRQFHQWUDWLRQRI1D2+LQ2122 -solutions added to PMNs) was used as negative controls.
Neutrophil isolation and activation
Neutrophils were isolated from human peripheral blood as described previously (22) . The resulting cell preparations contained >95% neutrophils. Isolated neutrophils were suspended in a modified Hanks' balanced salt solution (140 mM NaCl, 5 mM KCl, 1.3 mM CaCl 2 , 0.6 mM MgCl 2 , 0.3 mM Na 2 HPO 4 , 0.04 mM NaH 2 PO 4 , 4 mM NaHCO 3 , 5 mM glucose, 0.1% bovine serum albumin, pH 7.4) and used within 20 min of preparation. Neutrophils (10 7 cells/ml) were incubated with the MAPK kinase (MEK) inhibitor PD98059, the p38 MAPK inhibitor SB 203580, the phosphatidylinositol 3-kinase inhibitor wortmannin or the protein tyrosine kinase inhibitors genistein or herbimycin A for 20 min at 37°C, challenged with ONOO -or a solution of decomposed ONOO -for 30 min, and surface expression of L-selectin, CD11b, CD11a, or CD18 was analyzed. To assess whether ONOO -is active in the microenvironment of whole blood, in separate experiments, whole blood aliquots were challenged with ONOO -or decomposed ONOO -, and adhesion molecule expression was then analyzed.
Analysis of surface antigen expression
Direct immunofluorescence labeling of resting and treated neutrophils were performed as described (22, 23 
Raf-1 kinase assay
Raf-1 activity was determined by modifying the method of Gardner et al. (25) . In brief, lysates of unstimulated or ONOO --stimulated neutrophils (prepared as described above) were incubated with anti-Raf-1 antiserum or a control antiserum for 1 h at 4°C. Antigen-antibody complexes were isolated by incubation with protein A-Sepharose CL-4B for 1 h at 4°C. Protein ASepharose CL-4B was washed twice with ice-cold lysis buffer containing 0.5% Igepal CA-630, WZLFHZLWK3$1EXIIHUP03,3(6S+P01D&OJPODSURWLQLQFRQWDLQLQJ 0.5% Igepal CA-630, and once with PAN buffer. The ILQDOSHOOHWZDVUHVXVSHQGHGLQO3$1 buffer. Raf-1 activity was determined with the Raf-1 Kinase Cascade Assay kit (Upstate Biotechnology, Lake Placid, N.Y.) by adding unactive MEK1, unactive Erk-2, and ATP (200 0DQGWKHQP\HOLQEDVLFSURWHLQJDVVD\DQG>-32 3@$73&LDVVD\WRWKHVDPSOHV in accordance with the manufacturer protocols. The reaction mixtures were spotted onto phosphocellulose squares, which were washed thoroughly in 0.75% phosphoric acid and then in acetone and then counted for radioactivity (phosphorylated myelin basic protein).
Ras activation assay
Activated p21
Ras (Ras-GTP) from neutrophil lysates was affinity precipitated by using GST-Ras binding domain of Raf-1 (residues 1-149) fusion protein conjugated to agarose (Upstate Biotechnology) as described elsewhere (26) . The beads were washed extensively and boiled in reducing sample buffer. The eluted proteins were resolved on a 10% SDS-polyacrylamide gel, transferred to a PVDF membrane, probed with a mouse anti-Ras mAb (clone RAS10, Upstate Biotechnology), and visualized by using a goat anti-mouse secondary antibody conjugated to horseradish peroxidase (BioRad, Mississauga, Ontario) and a chemiluminescence detection system.
Culture of endothelial cells
HCAEC obtained from Clonetics Corp. (San Diego, Calif.) were cultured as described (22) . HCAEC (passages 3 to 6) seeded into 24-or 96-well microplates and grown to confluence were used in the experiments.
Neutrophil-endothelial cell adhesion assay
The adhesion assay was performed as in (22) . In brief, monolayers of HCAEC in 96-well PLFURSODWHVZHUHVWLPXODWHGZLWK/36JPORUYDULRXVFRQFHQWUDWLRQVRI2122
-for 4 h at 37°C in a 5% CO 2 atmosphere. The cells were then washed three times, and 2x10 5 51 Cr-labeled neutrRSKLOVLQOZHUHDGGHG,QVRPHH[SHULPHQWV2122 -was added with neutrophils to HCAEC treated with LPS or ONOO -for 4 h. In another set of experiments, LPS-activated HCAEC were incubated for 15 min with ENA-P$E JPO RU 023&-21 mAb (20 J/ml) before addition of neutrophils. Radiolabeled neutrophils were incubated with DREG-56 P$EJPO/P$EJPORU023&-21 mAb for 15 min before addition to HCAEC. After incubation of HCAEC with neutrophils with or without ONOO -for 30 min at 37°C on an orbital shaker at 90 rpm, loosely adherent or unattached neutrophils were washed WKUHHWLPHVDQGWKHHQGRWKHOLDOPRQROD\HUSOXVWKHDGKHUHQWQHXWURSKLOVZHUHO\VHGLQORI 0.1% Triton X-100. The number of adhered neutrophils in each experiment was estimated from the radioactivity of a control sample.
Expression of E-selectin and ICAM-1
After incubation for 4 h at 37°C in a 5% CO 2 DWPRVSKHUH ZLWK /36 JPO 2122 -or decomposed ONOO -, HCAEC were detached from the 24-well microplates by exposure to EDTA (0.01%) in PBS for 10 min at 37°C followed by gentle trituration. The cells were then stained with saturating concentration of fluorescein dye-conjugated anti-E-selectin or anti-ICAM-1 mAb for 30 min at 4°C, washed, and fixed in formaldehyde (3.9% in PBS), and immuno-fluorescence was analyzed with a flowcytometer as described previously (29) . Nonspecific binding was evaluated by using appropriately labeled mouse IgG 1 .
Data analysis
Results are expressed as means ±SEM. Statistical comparisons were made by ANOVA using ranks (Kruskal-Wallis test) followed by Dunn's multiple contrast hypothesis test to identify differences between various treatments, or by the Wilcoxon signed rank test and Mann-Whitney U test for paired and unpaired observations, respectively. P values <0.05 were considered significant for all tests.
RESULTS
ONOO
-regulates expression of L-selectin and 2 integrins on neutrophils Figure 1 reports representative results illustrating the impact of ONOO -on adhesion molecule expression on neutrophils. ONOO -down-regulated neutrophil surface expression of L-selectin ( Fig. 2A) , and up-regulated expression of CD11b in a concentration-dependent fashion (Fig. 2B) with apparent EC 50 YDOXHVRIWR06LPLODULQFUHDVHVZHUHGHWHFWHGLQ&'H[SUHVVLRQ (data not shown). The maximum changes that could be achieved with ONOO -were smaller than those evoked by 1 0SODWHOHW-activating factor (PAF) (55±3 and 72±5% decreases in L-selectin expression, and 68±5 and 85±4% increases in CD11b expression by ONOO -and PAF, respectively, n=6, both P<0.05). Neither decomposed ONOO -( Fig. 2) nor appropriately diluted NaOH (pH control) (data not shown) affected expression of L-selectin and CD11b expression. Furthermore, ONOO -0DGGHGWRZKROHEORRGHYRNHGVLPLODUFKDQJHVLQQHXWURSKLO/-selectin and CD11b expression as observed with isolated PMNs (Fig. 1). ONOO -at the concentrations tested did not cause significant decreases in neutrophil viability (data not shown).
Next, we investigated whether ONOO -LVDEOHWRPRGLI\WKHDIILQLW\RI 2 integrins. Formation of a higher affinity form of LFA-1 and Mac-1 is thought to involve conformational changes and DVVRFLDWLRQRIWKH,GRPDLQZLWKWKH-propeller domain (30, 31) . The mAb G-25.2 recognizes this latter domain in LFA-1 (31) . Incubation of PMNs with ONOO -was not associated with a detectable increase in staining with mAb G-25.2 (Fig. 3) . As a positive control, activation of cells with Mg 2+ and EGTA, which induces the formation of a higher-affinity form of LFA-1 without inducing clustering (32) , resulted in increases in mAb G-25.2 immunostaining (Fig. 3) .
Inhibition of MAPK kinase reverses ONOO --induced changes in CD11b/CD18 expression on neutrophils
The MAPK kinase (MEK) inhibitor PD98059 increased by approximately 13% neutrophil Lselectin expression without affecting CD11b/CD18 expression (Fig. 4) . PD98059 prevented ONOO --induced up-regulation of CD11b/CD18 expression in a concentration-dependent fashion, whereas it was a less effective inhibitor in reversing ONOO --induced down-regulation of L-selectin expression (Fig. 4) . Although both wortmannin and genistein alone down-regulated L-selectin expression (Fig. 4) , none of these inhibitors significantly affected ONOO --induced changes in L-selectin and CD11b/CD18 expression (Fig. 4) . Similar results were obtained with herbimycin A (data not shown). The selective p38 MAP kinase inhibitor SB 203580 (33) had little effect on ONOO --induced changes in CD11b/CD18 expression (Fig. 4) .
ONOO -activates Erk via the Ras/Raf-1/MEK signaling cascade
Incubation of neutrophils with ONOO -induced a time-and concentration-dependent increase in phosphorylation of Erk relative to unstimulated controls (Fig. 5A) . Phosphorylation of Erk was rapid, concordant with the kinetics of ONOO --stimulated up-regulation of CD11b/CD18 expression. The degree of maximal Erk phosphorylation observed with ONOO -0 ZDV somewhat less than that induced by PAF (Fig. 5A) . Because nitration and/or hydroxylation of aromatic compounds by ONOO -may lead to dysfunction of the affected proteins (34, 35), we have also assayed Erk activity by measuring the ability of neutrophil lysates to phosphorylate Elk-1, a specific target for Erk (24) . ONOO -increased Elk-1 phosphorylation in a concentrationdependent fashion (Fig. 6) . For instance, ONOO -0LQGXFHGD-fold increase in Elk-1 phosphorylation relative to unstimulated controls (Fig. 6) .
Because Erk activity in response to growth factors depends upon the sequential activation of Ras and the kinases Raf-1 and MEK (36-41), we examined whether ONOO -stimulation of Erk is similarly mediated via this cascade. Phosphorylation of MEK was rapid in onset and maximal within 2 min after addition of ONOO -to PMNs and it occurred in a concentration-dependent fashion (Fig. 5A) . ONOO -also evoked increases in neutrophil Raf-1 kinase activity within 2 min (Fig. 7A) . Raf-1 activity is, at least in part, regulated by binding of the active form of Ras (GTPbound Ras) to Raf-1 (42) . Ras activation was detected by affinity precipitation of GTP-bound active Ras with a glutathione-S-transferase-Ras (GST-Ras) binding domain fusion protein followed by immunoblotting with an anti-Ras antibody. As is shown in Figure 7B , ONOO -induced concentration-dependent association of Ras with the GST-Ras binding domain of Raf-1 within 2 min.
To provide further evidence that ONOO -stimulation of neutrophil Erk is mediated via Raf-1 and MEK, we tested whether PD 98059, a specific inhibitor that binds to MEK and prevents its phosphorylation and activation by Raf-1 or other kinases (43) , has an effect on Erk activation. Preincubation of PMNs witK3'0UHVXOWHGLQ±3% inhibition of ONOO -(100 0-stimulated Erk activity. PD 98059 also inhibited ONOO -0-induced up-regulation of CD11b/CD18 expression by 75± DW 0 Fig. 8) . A previous study reported that ONOO --induced Erk phosphorylation is mediated through activation of p38 MAPK in human neuroblastoma cells (44) . Although we detected enhanced phosphorylation of p38 MAPK in PMNs challenged with ONOO -, SB 203580 did not affect Erk phosphorylation (Fig. 5B) , indicating that Erk activation is human neutrophils is independent of p38 MAPK.
Effect of ONOO -on E-selectin and ICAM-1 expression
Flow cytometry analysis revealed that approximately 50% and 4% of untreated HCAEC expressed ICAM-1 and E-selectin, respectively ( Table 1) . Culture of HCAEC for 4 h with ONOO -resulted in slight increases in the overall expression of these adhesion molecules and in the percentage of cells expressing E-selectin ( Table 1) without affecting cell viability. Furthermore, when ONOO -was added together with LPS to HCAEC, expression of ICAM-1 and E-selectin was similar to those detected with LPS alone (data not shown).
ONOO -enhances neutrophil adhesion to human coronary artery endothelial cells
Only a few PMNs could bind to unstimulated HCAEC. Neutrophil adherence was enhanced 5-fold by activation of HCAEC with LPS (Fig. 9A) , whereas addition of ONOO -(0.1-0 initial concentrations) to HCAEC resulted in only 15% to 80% increases in the number of adherent neutrophils (Fig. 9A) . The number of adherent neutrophils was further enhanced when PMNs were added together with ONOO -to LPS-activated HCAEC (Fig. 9B) . On the other hand, ONOO -evoked only slight increases in neutrophil adherence when PMNs were added to HCAEC incubated with ONOO -for 4 h (Fig. 9C) . Because multiple receptors are involved in neutrophil adhesion to LPS-stimulated HCAEC even under non-static conditions (22, 29) , and ONOO -affected expression of both L-selectin and CD11/CD18 on PMNs, we assayed the contribution of L-selectin, 2 integrins and E-selectin to the binding interaction. A significant proportion of neutrophil attachment was blocked by mAbs binding to E-selectin (29±1%, n=3), L-selectin (22±1%) and CD18 (28±1%) (Fig. 9D) . The combination of these mAbs inhibited neutrophil adhesion by ~80% (Fig. 9D) . ONOO --stimulated PMN adhesion to LPS-activated HCAEC was blocked by mAbs binding to E-selectin (22±2%, n=3), L-selectin (10±2%) and CD18 (55±5%) (Fig. 9D) , indicating that ONOO -promoted CD18-dependent attachment. The combination of these three mAbs inhibited PMN adhesion by 80% to 88% (Fig. 9D) .
DISCUSSION
In this report, we describe a novel mechanism by which ONOO -can affect the inflammatory process, which is via the modulation of surface expression of adhesion molecules on human neutrophils. This leads to increased CD18-dependent adhesion of PMNs to the activated endothelium. We also examined the mechanisms of ONOO -signaling in neutrophils, observing a possible role for the Ras/Raf-1/MEK/Erk signaling pathway in ONOO --stimulated neutrophil responses.
The present study shows that at micromolar concentrations, ONOO -is capable of downregulating L-selectin and up-regulating CD11/CD18 expression on human isolated neutrophil granulocytes as well as on neutrophils in the microenvironment of whole blood. Our results suggest that this activation is most likely mediated via activation of Erk. Peroxynitrite stimulation of Erk was concentration-and time-dependent. Erk activation was detected by immunoblotting with anti-phospho-Erk antibodies and was confirmed by direct measurements of Erk activity by using the selective Erk target Elk-1. These latter observations exclude the possibility of the ONOO -inactivation of phosphorylated Erk. The kinetics of Erk activation by ONOO -in neutrophils and mitotic cells appears to be distinct, peaking at 2-5 min and 5-10 min, respectively (45, 46) . The effects of ONOO -were unlikely to be due to a nonspecific effect, since neither decomposed ONOO -nor appropriately diluted NaOH (pH control) activated neutrophils or stimulated Erk activity.
The ability of ONOO -to induce phosphorylation of MAP kinases in human neuroblastoma (44), rat-liver epithelial cells (47) , and PC12 cells (48) , together with the role of Erk in mediating neutrophil responses (16, 17, 20, 21) , led us to test whether ONOO -activation of Erk in neutrophils was similarly dependent on the MAP kinase pathway. Erk stimulation in response to protein tyrosine kinase receptors and some G protein-linked receptors proceeds via Ras, Raf-1 and MEK (36) (37) (38) (39) (40) (41) . Our data indicate that ONOO -stimulation of Erk in neutrophils involves this pathway also, because ONOO -stimulated Ras and Raf-1 kinase activity, evoked phosphorylation of MEK and the specific MEK inhibitor PD 98059 inhibited Erk activation by ONOO -, although this inhibition was incomplete (~80%). In human dopaminergic neuroblastoma SH-SY5Y cells, the peroxynitrite donor SIN-1 induced phosphorylation of p38 MAPK, followed by that of Erk and inhibition of p38 MAPK with SB 202190-suppressed Erk phosphorylation to the basal level (44) . Our findings were consistent with these observations. We also detected enhanced phosphorylation of p38 MAPK by ONOO -in neutrophils. However, SB 203580, a selective inhibitor of p38 MAPK, did not block ONOO --stimulated Erk phosphorylation and up-regulation of CD11b/CD18, indicating that neutrophil Erk activation by ONOO -is independent of p38 MAPK activation. The functional consequences and mechanism of neutrophil p38 MAPK activation by ONOO -remain to be investigated.
ONOO -crosses cell membranes at a rate significantly faster than the rates of its known decomposition pathways (49, 50) . The present observations suggest that, following diffusion into PMNs (and perhaps following intracellular generation), ONOO -initiates Erk activation via Ras, Raf-1 and MEK, similarly to that previously observed with other stimuli (17, 18) . Although this model represents a best fit for our data, it fails to provide a mechanism whereby ONOO -leads to activation of Ras. Whether ONOO -activation of Ras is G protein-dependent and the mechanisms whereby G protein activation leads to Ras and/or Raf-1 activation remain to be investigated. Furthermore, Mallozzi et al. (51, 52) reported that ONOO -up-regulates the tyrosine phosphorylation signal through activation of src kinases in human erythrocytes and bovine synaptosomes. Activation of src kinases could also lead to Ras activation. To our knowledge, the effects of ONOO -on neutrophil src kinases have not been reported. However, the failure of the tyrosine kinase inhibitors genistein and herbimycin A to affect significantly ONOO --induced changes in neutrophil adhesion molecule expression would support this notion.
The present data further suggest that Erk activation is required for ONOO -stimulation of CD11b/CD18 expression and consequently of neutrophil adhesion to HCAEC. Previous studies reported a tight correlation between Erk activation and homotypic neutrophil adhesion in response to chemoattractants (17) and arachidonic acid (18) . We also found that the degree of Erk inhibition by PD 98059 was similar to the degree of inhibition of CD11b/CD18 expression. However, PD 98059 appeared to be a less potent inhibitor of the ONOO -down-regulation of Lselectin expression, indicating the involvement of other, Erk-independent pathway(s) in adhesion VLJQDOLQJ:LWKUHVSHFWWR 2 integrin expression, ONOO -did not affect mAb G-25.2 expression. Activation of PMNs with Mg 2+ and EGTA, which results in the formation of a higher-affinity form of LFA-1 (32), increased the expression of mAb G-25.2. These results suggest that ONOO -does not alter the affinity of LFA-1, and probably of Mac-EXWUDWKHULWLQGXFHVFOXVWHULQJRI 2 integrins, and thereby increases the overall strength of binding. However, our results do not preclude the possibility that, in the presence of integrin ligands, ONOO -might affect a ligandinduced affinity increase secondary to integrin clustering.
Despite inducing L-selectin shedding from neutrophils, which was reported to attenuate PMN-HCAEC attachment (22, 53) , ONOO -actually promoted neutrophil adhesion to HCAEC. This augmentation was largely due to its action on neutrophils rather than on HCAEC in this interaction, because ONOO -produced only slight increases in the number of adherent PMNs to ONOO --activated HCAEC, and in the expression of E-selectin and ICAM-1 on HCAEC. Increases in both the intensity of staining for adhesion molecules and the percentage of HCAEC expressing E-selectin and ICAM-1 indicate that, in addition to up-regulating the expression on cells already expressing E-selectin and ICAM-1, ONOO -also induced expression of E-selectin on previously negative cells. Our findings on ICAM-1 expression are consistent with the observation that ONOO -decomposition catalysts reduced mesenteric ICAM-1 staining evoked by ischemia-reperfusion in the rat (12) . It should, however, be noted that ONOO -is a markedly less potent activator of HCAEC than LPS or TNF-.UHIDQGWKHSUHVHQWVWXG\1RDGKHVLRQ experiments were performed with neutrophils preincubated with ONOO -, since, by up-regulating CD18 expression, ONOO -may induce neutrophil aggregation and therefore make interpretation of the results difficult.
Taken together, the present and previous studies (9, 10, 12) suggest a dual role for ONOO -in the regulation of neutrophil trafficking. At nanomolar concentrations, ONOO -may exert an antiadhesive action (9); whereas at higher concentrations (1-0ZKLFKFRXOGEHFRQFHLYDEO\ achieved in vivo (51) , it promotes neutrophil adhesion. Such diametrically opposed actions of ONOO -can be understood by appreciating that the target(s) (i.e., the reaction substrate) of ONOO -, when pro-adhesive, is different from that when it is protective. Indeed, low amounts of ONOO -may react with serum albumin or glutathione to form nitrosothiols, which release NO (54) . However, such mechanism may not always be operational, for ONOO -decomposition catalysts were found to decrease endothelial P-selectin expression during reperfusion of the ischemic rat mesenterium (12) . In our PMN-HCAEC binding assay, P-selectin-dependent adhesion was not studied, since P-selectin expression occurs within 10-20 min after application of inflammatory stimuli and is sustained for about 60 min (55). Higher amounts of ONOO -may diffuse freely into cells to activate intracellular signaling pathways, including Ras and/or Raf-1, when the protection conferred by albumin, glutathione, and other antioxidants is overwhelmed (56) . This action would lead to changes in neutrophil adhesion molecule expression and ultimately to increased neutrophil adhesiveness. It is worth mentioning that inflammation is often associated with depletion of antioxidant capacity (57) , thereby unmasking and aggravating the deleterious actions of ONOO -.
Since the half-life of ONOO -at neutral pH is on the order of seconds, we cannot conclude at present whether the observed effects were a direct action of ONOO -or of one of its more stable decomposition products. These decomposition products are still a subject of debate. Hydroxyl radical (1) and peroxynitrous acid (or its activated isomer) with biological activity similar to that of hydroxyl radical (58) have been proposed as active intermediates to mediate the reactivity of ONOO -. In aqueous solution in the absence of antioxidants ONOO -may decompose to nitroxyl anion and singlet oxygen (59); therefore, it is unlikely for ONOO -to function as an NO-donating compound (9).
Our results may have relevance to excessive leukocyte trafficking in inflammation. For instance, enhanced ONOO -formation accompanying myocardial inflammation (7) may contribute to tissue leukocyte accumulation, and thereby to neutrophil-mediated tissue injury (12, 60) . Furthermore, exploring the pro-adhesive actions of ONOO -may be particularly relevant to understanding the beneficial effects of ONOO -scavangers and decomposition catalysts in attenuating leukocyte accumulation in inflammation (10) and ischemia-reperfusion injury (12) .
In summary, these data indicate that ONOO -activates neutrophil Erk via the Ras/Raf-1/MEK signaling cascade, leading to up-regulation of CD11b/CD18 expression, and promotes neutrophil adhesion to HCAEC via a CD18-dependent mechanism. Furthermore, our results also support the hypothesis that Erk activation in human neutrophils plays a critical role in the heterotypic adhesive responses of these cells. -for 2 min at 37°C, lysed, and immunoprecipitated with Raf-1 antiserum, and measured for Raf-1 kinase activity as described in methods. Control experiments performed in the absence of substrate or by using a non-specific control antiserum resulted in levels of Raf-1 activity below those of unstimulated lysate. Results shown are the mean ± SEM of four experiments; *P<0.05; **P<0.01 vs. unstimulated. Neutrophils were challenged with ONOO -(B) or with various concentrations of ONOO -or decomposed peroxynitrite (dP) for 2 min. (C) GTP-bound active Ras was isolated from neutrophil lysates by affinity precipitation with a GST-Ras binding domain fusion protein followed by immunoblot analysis with an anti-Ras antibody. Shown is a representative result; the experiment was repeated three times. -(B, C) were then added and incubated with HCAEC for 30 min at 37°C on an orbital shaker. Values are expressed as the mean ± SEM of six experiments in triplicate by using neutrophils from different donors; * P < 0.05; *** P < 0.001 vs. control; #P < 0.05 vs.
LPS-activated HCAEC. (D)
-to LPS-activated HCAEC and incubated for 30 min in the absence (medium) or presence of function -blocking monoclonal antibodies directed against CD18, CD62L and CD62E as indicated on the Y axis. The irrelevant mAb MOPC-21 (IgG1) was used as a negative control. Results ar expressed as the mean ± SEM of three experiments in triplicate by using neutrophils from different donors.
